Dr Reddy's shares rose over 2% post Q1 results, backed by steady margins and solid growth in India, Europe, and emerging markets. SEBI-registered analyst Rajneesh Sharma sees a bullish swing opportunity above ₹1,199-1,215 support. Technicals show RSI divergence and price holding trendline support. A move above ₹1,300 could confirm upside; YTD, the stock is down 9%.